Let's Talk ID cover image

President's Podcast: IDWeek 2022 Recap

Let's Talk ID

00:00

Is There a New Drug in the Pipeline?

In terms of novel antibacterial and novel antifungals, one study that stuck me is the Brazilian study which looked at liposomal amforid medicine as a single dose. I think in ID, a lot of the drugs are drying up either because we have resistant pathogens that are emerging or other issues. And I think it's critical for us to encourage studies on novel drugs. In terms of COVID-19, that's a topic that is dear to me because that's the data I keep looking. As much as I hate to admit, I guess the pandemic is still kind of smoldering. It's really important to continue the research we're doing on therapeutics

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app